65 results
Page 2 of 4
S-3ASR
fgv0pz
23 Sep 22
Automatic shelf registration
4:08pm
S-3ASR
EX-4.5
uzg2 cf32
23 Sep 22
Automatic shelf registration
4:08pm
8-K
EX-1.1
i6ybg fq28h
21 Jul 22
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
4:46pm
424B5
a72mya4pctq
21 Jul 22
Prospectus supplement for primary offering
4:43pm
424B5
qtnw2pkh8o9enx0594k
20 Jul 22
Prospectus supplement for primary offering
4:22pm
S-3
vv72wkb3t3h2 v3ua2pq
1 Jul 22
Shelf registration
4:36pm
S-3
EX-4.4
vs54j
1 Jul 22
Shelf registration
4:36pm
S-3
EX-4.5
y97eyokhil
1 Jul 22
Shelf registration
4:36pm
S-3
EX-1.2
gocx1dwxsdx
1 Jul 22
Shelf registration
4:36pm
DEF 14A
x6rpkqp4hym
29 Apr 22
Definitive proxy
7:01am
10-K
EX-10.19
80fvgo
14 Mar 22
Annual report
7:04am
10-K
u4ci07r8 v77
14 Mar 22
Annual report
7:04am
8-K
tca092n1
29 Nov 21
Departure of Directors or Certain Officers
5:09pm
10-Q
7ms70k
12 Aug 21
Quarterly report
8:53am
424B4
3uhpq8
17 Jun 21
Prospectus supplement with pricing info
4:50pm